Vol 5, No 19 (October 28, 2017): Annals of Translational Medicine (Focus on “II Meeting on Traslational Research on Melanoma by the Spanish Melanoma Group (GEM)”)

Preface

Special issue on II Translational Meeting from the Spanish Melanoma Group
Salvador Martin-Algarra, Salvador Martin-Algarra, On behalf of the Spanish Melanoma Group (GEM)
Annals of Translational Medicine
 2017;
5
(19)
:383
(October 2017)
PDF Pages: 383 Full Text (1272) Open Access Get Permission

Review Article

New trends in antitumor vaccines in melanoma
Marcos Vasquez, Shirley Tenesaca, Pedro Berraondo
Annals of Translational Medicine
 2017;
5
(19)
:384
(October 2017)
PDF Pages: 384 Full Text (3711) Open Access Get Permission
Molecular mechanisms of programmed cell death-1 dependent T cell suppression: relevance for immunotherapy
Miren Zuazo, Maria Gato-Cañas, Noelia Llorente, María Ibañez-Vea, Hugo Arasanz, Grazyna Kochan, David Escors
Annals of Translational Medicine
 2017;
5
(19)
:385
(October 2017)
PDF Pages: 385 Full Text (7224) Open Access Get Permission
Dendritic cell therapy in melanoma
Carmen Alvarez-Dominguez, Ricardo Calderón-Gonzalez, Hector Terán-Navarro, David Salcines-Cuevas, Almudena Garcia-Castaño, Javier Freire, Javier Gomez-Roman, Fernando Rivera
Annals of Translational Medicine
 2017;
5
(19)
:386
(October 2017)
PDF Pages: 386 Full Text (5774) Open Access Get Permission
Overcoming resistance to BRAF inhibitors
Imanol Arozarena, Claudia Wellbrock
Annals of Translational Medicine
 2017;
5
(19)
:387
(October 2017)
PDF Pages: 387 Full Text (11390) Open Access Get Permission
The combination of checkpoint immunotherapy and targeted therapy in cancer
Niki Karachaliou, Maria Gonzalez Cao, Aaron Sosa, Jordi Berenguer, Jillian Wilhelmina Paulina Bracht, Masaoki Ito, Rafael Rosell
Annals of Translational Medicine
 2017;
5
(19)
:388
(October 2017)
PDF Pages: 388 Full Text (8427) Open Access Get Permission
Predictive factors of response to immunotherapy—a review from the Spanish Melanoma Group (GEM)
Enrique Espinosa, Ivan Márquez-Rodas, Ainara Soria, Alfonso Berrocal, Jose Luis Manzano, Maria Gonzalez-Cao, Salvador Martin Algarra, On behalf of the Spanish Melanoma Group (GEM)
Annals of Translational Medicine
 2017;
5
(19)
:389
(October 2017)
PDF Pages: 389 Full Text (5020) Open Access Get Permission

Meeting Report

Report from the II melanoma translational meeting of the Spanish Melanoma Group (GEM)
Maria Gonzalez-Cao, Alfonso Berrocal, Susana Puig, Niki Karachaliou, Leticia De Matos-Arruda, Joan Seoane, David Escors, Carmen Alvarez, Jose Pedro Vaque, Aleix Prat, Claudia Wellbrock, Imanol Arozarena, Ivan Marquez-Rodas, Enrique Espinosa, Migue Angel Molina, Teresa Puertolas, Manuel Juan-Otero, Rosina Malagrida, Eloisa Jantus-Lewintre, Virtudes Soriano, Ana Arance, Jose Luis Manzano, Paul Lorigan, Thomas F. Gajewski, Rafael Rosell, On behalf of the Spanish Melanoma Group (GEM)
Annals of Translational Medicine
 2017;
5
(19)
:390
(October 2017)
PDF Pages: 390 Full Text (3448) Open Access Get Permission
Highlights of the season 2016–2017 by the Spanish Melanoma Group (GEM)
Ainara Soria, Jose Luis Manzano, Alfonso Berrocal, Enrique Espinosa, Ivan Marquez-Rodas, Maria Gonzalez-Cao, Salvador Martin-Algarra, On behalf of the Spanish Melanoma Group (GEM)
Annals of Translational Medicine
 2017;
5
(19)
:391
(October 2017)
PDF Pages: 391 Full Text (3546) Open Access Get Permission
Infomelanoma 2020: an online digital application designed to assist health professionals for melanoma treatment
Maria González-Cao, Mar Carrasco-Calvo, Ainara Soria, Alfonso Berrocal, Ana Arance, Susana Puig, Laura Alós, Santiago Viteri, Pablo Cerezuela, Salvador Martín-Algarra
Annals of Translational Medicine
 2017;
5
(19)
:392
(October 2017)
PDF Pages: 392 Full Text (2225) Open Access Get Permission

Disclosure:

The focused issue “II Meeting on Traslational Research on Melanoma by the Spanish Melanoma Group (GEM)” was commissioned by the editorial office, Annals of Translational Medicine without any sponsorship or funding.